NCT04776525View on ClinicalTrials.gov

Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2036

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

Ifosfamide

3 g/m2 each day for three days

DRUG

Doxorubicin

80 mg/m2 over four hours day 1

Trial Locations (2)

Unknown

RECRUITING

Haukeland University Hospital, Bergen

RECRUITING

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

Haukeland University Hospital

OTHER

lead

Oslo University Hospital

OTHER